Amalgam Rx Stock

Amalgam Rx is a digital health company that combines clinical and behavioral interventions to support patients, providers, & life sciences.

Sign up today and learn more about Amalgam Rx Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Amalgam Rx Stock

Amalgam Rx is the leader in bringing providers, life sciences, and digital solutions together. For more than 15 years, our team has been reimagining care delivery and creating lasting change across the chronic care ecosystem. Working in partnership with many of the world’s leading life sciences companies, Amalgam Rx has built an innovative platform for rapidly developing and scaling digital solutions — delivered through a wide variety of business models. Our proven end-to-end methodology enables the entire life cycle from R&D to commercialization. Amalgam’s solutions have generated more than 5 billion RWE data points utilized by patients and providers on three continents. For more information on how Amalgam Rx’s regulated, clinically validated technologies bring patients and providers closer together, reduce costs for payers, and unlock sustained value for partners, visit amalgamrx.com.

Funding History

June 2017$1.2M
January 2023$17.4M

Management

CMO

Suzanne Sysko Clough

CEO

Ryan Sysko

CTO

Matti Prasad

President

Chris Bergstrom

COO & CFO

Jennifer Main

Head Of Program Management

Danielle Malloy

Avhana General Manager

Noah Weiner

Head of CDSS & EHR Technologies

Nate Weiner

General Counsel and VP of Regulatory & Quality

Jason Brooke

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo